4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-057054
EVP,Chief Reg.&Quality Officer sold 226 shares at $15.58 ($3,521)
- EVP,Chief Reg.&Quality Officer acquired 765 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Lewis Tanya · EVP,Chief Reg.&Quality Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-28 | Exercise or conversion : show line 1 in the form | +765 | 765 | D | ||
| 2020-10-30 | Sale : show line 2 in the form | −226 | $15.58 | $3,521 | 539 | D |
| Open-market sales · 226 sh · avg $15.58 · $3,521 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2020-10-28 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −765 | 765 | 2,295 | D |
Loading xslF345X03/doc4.xml…